English | Español
Patient Daily | Apr 24, 2023

Syft, a GHX Company, Achieves Imprivata Single Sign-On Certification
Patient Daily | Apr 24, 2023

Global Healthcare Exchange Announces Plan to Acquire Prodigo Solutions
Patient Daily | Apr 24, 2023

2022 GHX Millennium Club Honorees Are Transforming the Healthcare Supply Chain
Patient Daily | Apr 24, 2023

Tempus Announces Seven Abstracts Accepted For Presentation at the American Association for Cancer Research Annual Meeting 2023
Patient Daily | Apr 24, 2023

Horizon Therapeutics plc Announces UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be Presented at the 2023 American Academy of Neurology (AAN) Annual Meeting
Patient Daily | Apr 24, 2023

Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community
Patient Daily | Apr 24, 2023

Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement
Patient Daily | Apr 24, 2023

Horizon Therapeutics plc Announces FDA Approval of an Update to the Indication Language for TEPEZZA® (teprotumumab-trbw) to Specify its Use in Thyroid Eye Disease (TED) Patients Regardless of Disease Activity or Duration

Trending
+ Community
Patient Daily | Apr 28, 2025

ENT Practice Expert: AOCOO-HNS Clinical Assembly will feature 'at least four sessions that seem particularly valuable for physicians'
+ Pharmaceuticals
Patient Daily | Apr 28, 2025

Alliance Pharmacy CEO on FDA compounded tirzepatide block: The data used is not 'enough to say the shortage is really over'
+ Pharmaceuticals
Patient Daily | Apr 29, 2025

Eli Lilly boosts federal lobbying spend as it ups legal pressure on compound pharmacies
+ Pharmaceuticals
Patient Daily | Apr 23, 2025

Empower Pharmacy CEO on pharmaceutical industry pricing disparities: 'Is it fair to charge one person in another country 10 times more?'